News
Following the success of our previous roundtables, during which research leaders exchanged ideas on data issues and how they are overcoming them, this intimate session (limited to 6–8 participants) ...
Register with Scientific Computing World and gain unparalleled access to premium content and invaluable resources designed to keep you informed and ahead of the curve. By joining our community, you’ll ...
Register with Scientific Computing World and gain unparalleled access to premium content and invaluable resources designed to keep you informed and ahead of the curve. By joining our community, you’ll ...
The Photonics100 is focused on those working on the technical side of innovation – the thinkers, makers, and doers bringing photonics breakthroughs to life. We plan to publish the 2026 list later in ...
In-depth reports & technical articles: Access insightful reports and whitepapers offering actionable information to support informed decision-making. Professional networking: Connect with a vibrant ...
The researchers introduce the term ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufacturing—a biomanufacturing method to produce chemicals without relying on living ...
Register with Scientific Computing World and gain unparalleled access to premium content and invaluable resources designed to keep you informed and ahead of the curve. By joining our community, you’ll ...
Propel your career and projects forward with full articles and exclusive content. Sign up now to unlock Scientific Computing World’s premium access.
Register with Scientific Computing World and gain unparalleled access to premium content and invaluable resources designed to keep you informed and ahead of the curve. By joining our community, you’ll ...
Exclusive webinars & round tables: Be among the first to learn about and join upcoming webinars and round tables addressing key issues in scientific computing. In-depth reports & technical articles: ...
Eviden has been awarded a 50-million-euro contract with the Serbia’s Office for IT and eGovernment. Together, Eviden and the Serbian administration will deploy a National AI Factory – composed of an ...
New modalities, new tools: choosing a flexible digital platform for drug discovery (Image: Shutterstock) With small molecule research being the dominant modality for decades, many legacy data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results